logo
Plus   Neg
Share
Email

Sanofi Declares Offer For Kiadis Unconditional; All Offer Conditions Now Satisfied

Sanofi (SNYNF,SNY), Sanofi Foreign Participations B.V., and Kiadis reported that a total of 95.03% of the Kiadis shares have been tendered to Sanofi at settlement date. Sanofi declared the offer unconditional. All offer conditions are now satisfied or waived. Settlement of the shares and payment of the offer price will take place on 16 April 2021.

The offeror noted that shareholders who have not tendered their shares during the acceptance period will have the opportunity to tender their shares during the post-closing acceptance period which will start on 14 April 2021 and end on 28 April 2021.

Sanofi Foreign Participations B.V. and Kiadis shall seek to procure the delisting of the shares on Euronext Amsterdam and Euronext Brussels as soon as possible.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Walt Disney World, the Orlando, Florida-based entertainment complex, is easing the health safety guidelines that were rolled out to prevent the spread of the ongoing COVID-19 pandemic. The complex is ending temperature checks in a phased manner following the advice of the Centers for Disease Control and Prevention (CDC) and local health officials. Frito-Lay North America, the convenient foods division of food and beverages giant PepsiCo, Inc., is recalling select Ruffles All Dressed Potato Chips citing the possible presence of undeclared milk ingredients, a known allergen, the U.S. Food and Drug Administration said. According to the agency, the recalled products may have distributed regionally to Walmart's Sam's Club Warehouses. Pfizer Inc. (PFE) and BioNTech SE (BNTX) announced Friday that they have initiated the Biologics License Application (BLA) process with the U.S. Food and Drug Administration (FDA) for approval of their mRNA vaccine to prevent COVID-19 in individuals 16 years of age and older. The companies initiated...
Follow RTT